MRI imaging
DeviceNeuromelanin sequence imaging
NCT Number: NCT05513794
In order to develop an image analysis system that automatically detects and quantifies neuromelanin, this study aims to construct a database of a wide sample by collecting brain MRI neuromelanin images prospectively.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Severance Hospital, Yonsei University Health System, Seoul, Seodaemun gu, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Parkinsin group
Inclusion criteria
Exclusion criteria
Healthy volunteer group
Inclusion criteria
Exclusion criteria
Neuromelanin sequence imaging
Time frame: Within 1 weeks after enrollment
Descriptive Statistics for Neuromelanin Volume Measured by MRI Image by Age
Time frame: Within 1 weeks after enrollment
Descriptive Statistics for Neuromelanin Volume Measured by MRI Image by group
Heuron Inc.
Industry
Prospective Data Collect Study for Development of Neurimelanin Image Analysis System
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06133283
Basal Ganglia Diseases, Brain Diseases
San Antonio, Texas, United States
View Trial DetailsNCT05766813
Basal Ganglia Diseases, Brain Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07723027
Basal Ganglia Diseases, Brain Diseases
Shakargarh, Punjab Province, Pakistan
View Trial DetailsNCT07361250
Basal Ganglia Diseases, Brain Diseases
Wuhan, Hubei, China
View Trial Details